Summary
Gilead Sciences, Inc. (GILD) filed an 8-K on July 25, 2018, to announce its financial results for the second quarter ended June 30, 2018. The filing primarily directs investors to a press release (Exhibit 99.1) containing detailed financial performance information. Gilead presented both GAAP and non-GAAP financial measures, with management emphasizing the utility of non-GAAP data for operational and strategic insights, while cautioning that it should supplement, not replace, the understanding derived from GAAP statements. Investors should review the press release for specific figures related to revenue, earnings per share, and other key financial metrics for the quarter. The company highlighted the use of non-GAAP measures, which are commonly used in the industry to provide a clearer view of underlying business performance, free from certain accounting adjustments. A reconciliation between GAAP and non-GAAP figures is available within the press release, offering transparency for investors to evaluate the company's financial health and operational efficiency.
Key Highlights
- 1Gilead Sciences announced its Q2 2018 financial results via an 8-K filing on July 25, 2018.
- 2The core financial details are presented in an accompanying press release (Exhibit 99.1).
- 3The company provided both GAAP and non-GAAP financial results for the quarter.
- 4Gilead's management views non-GAAP financial information as a useful tool for investors.
- 5Non-GAAP measures are used internally for operating, budgeting, and financial planning.
- 6Investors are advised to use non-GAAP information to supplement, not replace, GAAP financial analysis.
- 7A reconciliation of GAAP to non-GAAP financial measures is available in the press release.